Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Sotgiu and Dina Visca.
Giovanni Sotgiu
Connection Strength
2.493
Dina Visca
  1. Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. J Bras Pneumol. 2021; 47(4):e20210076.
    View in: PubMed
    Score: 0.239
  2. The Role of Blood Gas Analysis in the Post-Acute Phase of COVID-19 Pneumonia. Arch Bronconeumol (Engl Ed). 2021 Jun 17.
    View in: PubMed
    Score: 0.238
  3. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology. 2021 Mar-Apr; 27(2):151-165.
    View in: PubMed
    Score: 0.231
  4. Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients. Pulmonology. 2021 Sep-Oct; 27(5):452-455.
    View in: PubMed
    Score: 0.231
  5. Tuberculosis in the time of COVID-19: quality of life and digital innovation. Eur Respir J. 2020 08; 56(2).
    View in: PubMed
    Score: 0.224
  6. Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis. J Asthma. 2020 12; 57(12):1365-1371.
    View in: PubMed
    Score: 0.209
  7. Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2019 03; 53(3).
    View in: PubMed
    Score: 0.203
  8. Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study. Respir Med. 2019 04; 150:95-100.
    View in: PubMed
    Score: 0.203
  9. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. J Bras Pneumol. 2018 Apr; 44(2):153-160.
    View in: PubMed
    Score: 0.190
  10. Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology. 2021 May-Jun; 27(3):248-256.
    View in: PubMed
    Score: 0.058
  11. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Front Med (Lausanne). 2020; 7:572485.
    View in: PubMed
    Score: 0.057
  12. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
    View in: PubMed
    Score: 0.057
  13. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 07; 56(1).
    View in: PubMed
    Score: 0.056
  14. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020 Jul - Aug; 26(4):233-240.
    View in: PubMed
    Score: 0.055
  15. Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation. J Bras Pneumol. 2019 Apr 25; 45(2):e20180324.
    View in: PubMed
    Score: 0.051
  16. Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. Eur Respir J. 2018 07; 52(1).
    View in: PubMed
    Score: 0.048
  17. Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management. Curr Opin Pulm Med. 2018 05; 24(3):244-252.
    View in: PubMed
    Score: 0.048
  18. Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico. Eur Respir J. 2018 03; 51(3).
    View in: PubMed
    Score: 0.048
  19. Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use. Clin Respir J. 2018 May; 12(5):1989-1990.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.